NA 731 Renal Pathophysiology PDF Fall 2022

Document Details

SurrealCoral448

Uploaded by SurrealCoral448

Tags

renal pathophysiology kidney function acute kidney injury medical physiology

Summary

This document covers renal pathophysiology, including renal anatomy, physiology, assessment, acute kidney injury, and chronic kidney disease, for a nurse anesthesia class. It provides definitions, explanations, and diagnostic data.

Full Transcript

# NA 731 Pathophysiology for Nurse Anesthesia II Fall 2022 ## Renal Pathophysiology ### Content Outline - Physiology review - Assessment of kidney function - Acute kidney injury - Chronic kidney disease - Renal transplant ## Renal Anatomy - Retroperitoneal → T12 - L4 with right slightly lower t...

# NA 731 Pathophysiology for Nurse Anesthesia II Fall 2022 ## Renal Pathophysiology ### Content Outline - Physiology review - Assessment of kidney function - Acute kidney injury - Chronic kidney disease - Renal transplant ## Renal Anatomy - Retroperitoneal → T12 - L4 with right slightly lower than left - Functional unit: nephron - Complex tubule system with interaction with vascular system - Innervation - SNS: Preganglionics from T8-L1 - PSNS: CN X (vagus) to kidney and pudendal nerve (S2, S3, S4) to the ureters - Nociception = afferent SNS fibers from T10-L1 - Need at least a T10 epidural or ESP for a nephrectomy ## Renal Functions - **Functions** - Maintain ECF composition via regulation of ionic composition and osmolality (osmolality = Na concentration) - Conserve non-ionic components: glucose, amino acids, etc - Excretion of waste products - Regulates arterial blood pressure - Endocrine function → RASS, erythropoietin, vitamin D - vitamin D: when activated, will increase Ca2+ absorption from Gl tract - erythropoietin: stimulates red blood cell production - Chronic renal disease: anemia 2/2 deficiency of erythropoietin; hypocalcemia 2/2 impaired Ca2+ absorption ## Assessment of Renal Function: Diagnostic Data ### Glomerular Filtration Rate (GFR) - Glomerular filtration rate - the best overall measure of renal function - GFR = & × (ΔΡ – ΔΠ) - Kf: surface area for filtration - AP: difference in hydrostatic forces across the membrane - AΠ: difference in osmotic pressures across the membrane - In prerenal failure, progressing disease will cause a decrease in the surface area for filtration (Kf) - In prerenal failure, hypovolemia will cause a decrease in the hydrostatic force differential (AP) - GFR typically mirrors cardiac output - Normal GFR = 125-140mL/min → decreases 8 mL/yr after 30 YO - GFR < 60 mL/min indicates CKD - Evaluated by assessing: - Creatinine: 0.6-1.3 mg/dL → freely filtered - Creatinine clearance: 110-140mL/min → the most reliable measure of GFR - Creatinine clearance < 30: do not administer drugs that rely on renal clearance (ex: sugammadex) - Blood urea nitrogen: 10-20 mg/dL - Protein: < 150mg/day ### Renal Tubular Function - Specific gravity of urine (specific gravity is the concentration of fluid when compared to water; the closer to 1, the more dilute the fluid) - In the absence of diuretics, glycosuria, proteinuria this should be < 1.018 - Fractional excretion of sodium: measure of the percentage of filtered sodium excreted in urine - The most useful differentiation between prerenal and renal disease - FENa < 1%: normally functioning tubules are conserving sodium → suggestive of prerenal disease - FENa > 2%: tubules unable to conserve sodium → consistent with tubular dysfunction - Urinalysis: analysis for pH, spec gravity, microscopy - Presence of protein, blood, glucose, hemoglobin, leukocytes, and toxins can indicate pathological state ## Acute Kidney Injury - Characterized by deterioration of renal function over a period of hours to days → results in failure of kidney to excrete wastes and maintain fluid homeostasis - Affects up to 20% of hospitalized patients and 50% of ICU patients - Most common cause: hypotension and hypovolemia - Symptoms: asymptomatic, malaise, weight loss, orthostatic hypotension, volume overloaded (cirrhosis), dyspneic. Dx: - Creatinine increase 0.3mg/dL in 48hrs, or 1.5X baseline within 7 days - Abrupt decrease in urine output to < 0.5 mL/kg/hr or < 500 mL/day - Can be oliguric or nonoliguric ## Etiology of AKI ### Prerenal disease - Caused by inadequate renal perfusion - Often due to CHF, liver dysfunction, or sepsis - Most common form of AKI - Rapidly reversible - Induction of anesthesia or poor HD management during an anesthetic can lead to prerenal disease - Urine indices are often normal - Blood and urine specimens must be analyzed to determine cause, before treatment ### Intra/Intrinsic Renal Disease - Caused by injury to A/P of kidney - Can be due to injury to glomerulus, tubules, interstitium, or renal vasculature - Can be due to toxic drug effects → ABX (most often aminoglycosides or vancomycin) and NSAIDs - Can have nephritic (hematuria) or nephrotic pattern (proteinuria) ### Postrenal Disease - Caused by obstruction of urinary flow tract - Often due to prostatic hypertrophy, stones, tumor bulk - Least common but most easily reversible type of AKI - Potential for recovery is inversely related to the duration of obstruction Dx: often with U/S ## Complications of AKI - Most result from impaired fluid balance and/or electrolyte homeostasis - Volume overloading is common - Neuro: confusion, somnolence, seizures | Risk Factors for AKI | Pathophysiologies | |-------------------------|-------------------------------------------------------------------------------------| | High-risk surgical procedures | due to the accumulation of protein and amino acids in blood and fluid overload | | | CV/pulmo: HTN, CHF, pulmonary edema | | | due to sodium and, thus, fluid retention | | | EKG: arrhythmias with peaked T waves, wide QRS | | | Due to hyperkalemia | | | Hematologic: anemia, decreased vitamin D function, uremia-induced platelet dysfunction | | | Decreased EPO can lead to Hct between 20-30% | | | Decreased vitamin D function can cause hypocalcemia → deficiency in Ca2+ (clotting factor 4) → increased bleeding risk | | | Metabolic: hyperkalemia, hyperphosphatemia, hypocalcemia, hypermagnesemia, hyponatremia, hypoalbuminemia, metabolic acidosis | | | GI: anorexia, nausea, vomiting, ileus, and upper GI bleeding | | | Infection risk increases | | Advanced age | | | Preexisting renal insufficiency | | | CHF | | | Diabetic neuropathy | | | Hypertensive neuropathy | | | Liver failure | | | Pregnancy-induced HTN (preeclampsia) | | | Autoimmune disease | | | SLE | | | Sepsis/shock | | | Renal revascularization | | | Aortic cross-clamping | | | Cardiopulmonary bypass | | | Urologic surgery | | | Transplantation | | | Trauma | | | Nephrotoxins | Aminoglycoside and vancomycin ABX | | | Radiocontrast Dyes | | | NSAIDs | - Most of these adverse outcomes can be treated and even eliminated with hemodialysis ## Treatment of AKI - GOAL: limit further renal injury while correcting fluid, electrolyte, and acid-based arrangements - Fluid resuscitation and vasopressor therapy are universal treatments for prevention and management of AKI Balanced salt solutions and LR can be used →0.9% NS has been associated with hyperchloremic metabolic acidosis, with hyperkalemia - Norepinephrine and vasopressin are used to maintain MAP between 65-70mmHg - Dopamine use is not supported by literature to treat or prevent AKI → can also lead to tachycardia | Dosage | Receptor | Effects | |-----------|----------|---------------------------------------------------------------------| | 0.5-2 mcg/kg/min | D1 | increased renal and mesenteric blood flow | | 2-10 cg/kg/min | B1 | increased inotropy, increased CO | | > 5 mcg/kg/min | | increased NE release (indirect action) | | 10-20 mcg/kg/min | A1 and B1 (mostly A1) | vasoconstriction | - Fenoldopam - D1 agonist that increases renal perfusion/blood flow → clinical trials show no true benefit in treatment of AKI - Loop diuretics can be used with hypervolemic, non-anuric AKI - N-acetylcysteine and mannitol can decrease injury related to radiopaque dyes - Manage blood glucose - CRRT ## Pharmacology in AKI - Selection of drugs that do not depend on kidney for excretion is ideal, but not always possible - As long as creatinine clearance is > 30 mL/min, drug doses rarely must be altered - Loading doses will require no alteration, unless the patients VD has changed due to fluid overload - This can affect water soluble agents - Dosing intervals will increase - Drugs with toxic and/or active metabolites should be avoided altogether - Nephrotoxins should be avoided → includes NSAIDs, some ABX (aminoglycosides and vancomycin), contrast dyes - Avoid drugs that decrease renal perfusion: ACEIs, ARBS, NSAIDs, diuretics ## Anesthetic Management of AKI - Only lifesaving surgery should be performed in patients with AKI due to high mortality and morbidity among this population - Goals 1. Maintain adequate systemic BP and cardiac output 2. Avoid other renal insults → drug injury, hypovolemia, hypoxia - Preoperative evaluation: EKG, blood chemistries, CBC, coagulation assessment, urine indices 1. With any respiratory issues a chest radiograph is ordered 2. Preop dialysis in those at high-risk 3. DDAVP for platelet dysfunction in those undergoing higher-risk procedures - Intraoperative: 1. Large bore IVs (≥18g) 2. Avoid succinylcholine with hyperkalemia 3. Correct anemia 4. Properly maintain intravascular volume 5. Avoid morphine, tramadol, and meperidine since they reduce GFR and have toxic metabolites ## Chronic Kidney Disease - Progressive, irreversible deterioration of renal function resulting from a wide variety of diseases - Leading cause is diabetes mellitus, followed closely by hypertension - Large racial disparity → ESRD rate in AA patients is 3.6X Caucasians; Native American rate is 1.8X - Most often this is due to untreated hypertension - ~15% of American population has CKD - Half of Americans will develop CKD in their lifetime - Diagnosed when GFR < 60mL/min for > 3 months - Decrease in GFR to less than 25mL/min will progress to ESRD requiring dialysis and transplantation | Stages of CKD | GFR | Stage | Electrolyte imbalances | Uremic coagulopathy | |--------------|-----------|----------|------------------------------|-----------------------------| | G1 | > 90 | 1 | Hyperkalemia | Increased bleeding time | | G2 | 60-89 | 2 | Hypermagnesemia | Platelet dysfunction | | G3a | 45-59 | 3 | Hyperphosphatemia | Neurologic changes | | G3b | 30-44 | 3 | Hypocalcemia | Autonomic changes | | G4 | 12-29 | 4 | Metabolic acidosis | Encephalopathy | | G5 | <15 | 5 | Unpredictable fluid volume | Peripheral neuropathy | | | | | Anemia | Cardiovascular changes | | Albuminuria Stage | Albumin Excretion Rate | | | | | A1 | <30 mg/day | | Increased cardiac output | CHF | | A2 | 30-300 mg/day| | O2-heme curve to right | Dyslipidemia | | A3 | > 300 mg/day| | Renal osteodystrophy | Systemic HTN | | | | | Pruritis | | - Systemic HTN increases left ventricular hypertrophy, CHF, CAD, and cerebrovascular disease - Also speeds the development of ESD ## Cardiovascular Effects of Chronic Kidney Disease ## Peritoneal vs Hemodialysis | Peritoneal Dialysis | Hemodialysis | |---------------------------|-------------------| | Used by about 10% of patients | Much more common | | Anchored catheter is placed in the peritoneal cavity for infusion of dialysate that remains for several hours | Involves the diffusion of solutes between the blood and dialysate | | Via diffusion, solute transport occurs until fresh fluid is exchanged for the old fluid | Blood is heparinized and passed through a dialyzer that establishes a countercurrent in a semipermeable membrane | | Best for patients that do not tolerate rapid fluid shifting like those with angina or CHF | All dialysis parameters are changed regularly by physician and tailored for patient needs | | Very few absolute contraindications | Mortality rate is ~16% (down from 30% 20 years ago) and is likely due to cardiovascular disease/arrhythmia and/or sudden cardiac arrest | | Scarring can interfere with some surgeries | Limits site for vascular access | | Peritonitis is most serious complication | | | Hospitalization rates are slightly higher than with hemodialysis | | ## Anesthetic Mgt of CKD: Preop - General approach is similar to management of AKI → optimize modifiable risk factors and minimize risk factors and minimize further kidney injury - Preop eval - Patients with impaired 02 delivery are at greatest risk - A Lees Index (CRI) of >/= 2 with less than 4 METs requires additional workup - BP should be controlled prior to elective - surgery → antihypertensives should be continued, but there is a trend for holding ACEI and/or ARB on day of surgery, particularly when the potential for blood loss is great or neuraxial is used - Blood sugar < 180mg/dL - K < 5.5mEq/dL - May need intervention to improve blood quality - DDAVP, EPO, iron - IV access and BP monitoring are tailored to each patient's needs and the needs provided by the procedure Arterial monitoring - the responsiveness to fluid can be predicted in the paralyzed, mechanically ventilated patient in sinus rhythm → basis for FloTrac - Use of femoral artery can be the best option because it will be associated with the lowest infection risk - For high-risk patients central and/or PA catheters can be of value - TEE is an alternative to evaluate hemodynamic status - Vascular access requires avoiding the extremity with AV fistula, but most also consider future access by avoiding the nondominant arm - You can use temporary access, if necessary, but this is not the best option ## Anesthetic Management of CKD: Induction - Most often, ESRD patients respond to induction of anesthesia as if they were hypovolemic or "volume contracted" - Hypotension is most likely → risk is increased when the patient is uremic or on anti-HTN - Induction drugs should be titrated to effect to prevent hemodynamic fluctuation - RSI is often necessary - Succinylcholine: OK to use even with K < 5.5mEq/dL → response is not exaggerated in patients with CKD - Rocuronium: may be the best option, but is sugammadex a possibility? - Since SNS activity is impaired, which comes with the ability to compensate, then even small changes to management can lead to significant decrease in systemic blood pressure ## Anesthetic Management of CKD: Maintenance: - General anesthesia with a balanced technique is a safe and effective plan - volatile anesthetics are not dependent on renal function - Sevoflurane might be avoided because it can lead to fluoride toxicity and/or production of compound A → patients with ESRD are at increased risk of dysfunction - TIVA is an option and EEG monitoring can help titrate medications - Cerebral oximetry may be useful in high-risk patients - Hemodynamics are expected to be labile, and defibrillator must be available - Neuromuscular blockade should be avoided if possible - Rocuronium and vecuronium are subject to reduced clearance - Laudanosine can lead to seizure activity - Neostigmine and edrophonium are subject to reduced clearance, so the risk of re-curarization is not very great. - Sugammadex appears safe and effective with CKD with creatinine clearance > 30mL/min - Opioids lack serious cardiac depressant effects and when used can reduce need for VA - M6G can accumulate ## Anesthetic Management of CKD: Regional & Positioning: - Brachial plexus block (supraclavicular, infraclavicular, axillary are all appropriate) is useful for placing vascular access for chronic hemodialysis - The presence of uremic neuropathies should be assessed and documented prior to provision of regional anesthesia - A T4-T10 sympathetic block may improve renal function by attenuating vasoconstriction and suppressing surgical stress - All types of regional are possible, but you must consider where the vascular access is and consider for future placement. - Protect hemodialysis access - Consider poor nutritional status and effects on skin integrity ## Renal Transplantation - Transplant patients live typically 4 years longer than a dialysis patient - Living donors are preferred over deceased donors - Donor kidney is transplanted into the lower abdomen and received vascular supply from iliac vessels, then the ureter is anastomosed directly to the bladder - Management - can be regional or general, but SNS blockade can block control of systemic pressure - Most receive antirejection drugs and steroid prior - Renal function is not affected by choice of anesthetic - Traditional management called for aggressive crystalloid infusion by targeting specific blood pressure and central venous pressure - Dobutamine is the most appropriate inotrope - Cardiac arrest has been reported when the clamp is removed due to entrapment of renal preservative solution

Use Quizgecko on...
Browser
Browser